HERPES SIMPLEX 2
Clinical trials for HERPES SIMPLEX 2 explained in plain language.
Never miss a new study
Get alerted when new HERPES SIMPLEX 2 trials appear
Sign up with your email to follow new studies for HERPES SIMPLEX 2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Common cold sore drug tested as potential Alzheimer's slowing treatment
Disease control CompletedThis study tested whether a high dose of the common antiviral drug Valtrex (valacyclovir), used to treat herpes, could slow the progression of mild Alzheimer's disease. It involved 130 patients who had both Alzheimer's and evidence of a herpes simplex virus infection. Over 18 mon…
Matched conditions: HERPES SIMPLEX 2
Phase: PHASE2 • Sponsor: Columbia University • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Common cold sore drug investigated to fight Alzheimer's
Disease control CompletedThis study tested whether a high dose of the antiviral drug valacyclovir, commonly used for herpes, could slow down early memory loss linked to Alzheimer's disease. It involved 50 older adults who had mild memory problems, tested positive for herpes simplex virus, and showed earl…
Matched conditions: HERPES SIMPLEX 2
Phase: PHASE2 • Sponsor: New York State Psychiatric Institute • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC